Igyxos: Raising the profile of a novel infertility treatment

“The team provided valuable support in raising our visibility through thought leadership articles, advertorials and targeted media coverage on the back of our recent newsflow. This integrated communications campaign has significantly raised awareness of our innovative approach to treating infertility as a couples issue, positioning us well for talks with investors and partners.”

Florent Ferré
CEO of Igyxos Biotherapeutics

Objectives

Raise awareness of the company’s novel monoclonal-based approach to treating both female and male infertility, in advance of announcing ‘data’ results from the company’s Phase 1 clinical trial
Highlight the company’s recent milestone including a successful financing and positive Phase 1 clinical data
Post regularly on LinkedIn to build audience and create engagement

Strategy

Commissioned a white paper (WP) highlighting the lack of innovation in the fertility field
Secured a media-buy with top trade publication, La Biotech, to place the white paper
Media relations around two news releases relating to a successful financing and clinical data
On the ground support at leading industry events to secure in-person media interviews

Results

High impact quality WP content piece published
Strong coverage in trade media, including seven pieces of earned media secured over a four-month period, alongside press releases and multiple thought leadership opportunities
Around 20 LinkedIn posts, securing good engagement
Enhanced company’s visibility in the fertility treatment space ahead of investor & partner meetings during JP Morgan week 2026